13060-14-5

Basic information

• Product Name: C10894
• Synonyms: C10894;YANGAMBIN;(+)-O,O-Dimethyl lirioresinol B;(1S)-1β,4β-Bis(3,4,5-trimethoxyphenyl)-3aβ,4,6,6aβ-tetrahydro-1H,3H-furo[3,4-c]furan;(1β,5β)-2β,6β-Bis(3,4,5-trimethoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane;[1S,(+)]-3aβ,4,6,6aβ-Tetrahydro-1β,4β-bis(3,4,5-trimethoxyphenyl)-1H,3H-furo[3,4-c]furan;Lirioresinol B dimethyl ether;Lrioresinol B dimethyl ether
• CAS NO: 13060-14-5
• Molecular Formula: C₂₄H₃₀O₈
• Molecular Weight: 446.4902
• Mol File: 13060-14-5.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 556.1°C at 760 mmHg
• Flash Point: 221.1°C
• Appearance: /
• Density: 1.183g/cm³
• Vapor Pressure: 7.78E-12mmHg at 25°C
• Refractive Index: 1.537
• CAS DataBase Reference: C10894(CAS DataBase Reference)
• NIST Chemistry Reference: C10894(13060-14-5)
• EPA Substance Registry System: C10894(13060-14-5)

Safety Data

• Hazardous Substances Data: 13060-14-5(Hazardous Substances Data)

Usage

General Description

C10894 is a chemical compound with the molecular formula C23H36O3. It is classified as a steroid and is known by the name androstanolone. C10894 is a synthetic androgen and anabolic steroid that is used primarily in the treatment of hypogonadism and other hormonal imbalances. It works by binding to and activating the androgen receptor, leading to an increase in muscle mass and strength. Androstanolone has also been investigated for its potential use in the treatment of breast cancer, osteoporosis, and other conditions related to hormone imbalances. However, due to its potential for abuse and side effects, it is a controlled substance and has limited medical use.

InChI:InChI=1/C24H30O8/c1-25-17-7-13(8-18(26-2)23(17)29-5)21-15-11-32-22(16(15)12-31-21)14-9-19(27-3)24(30-6)20(10-14)28-4/h7-10,15-16,21-22H,11-12H2,1-6H3/t15-,16-,21+,22+/m0/s1

Upstream product

• 487-35-4 (+)-syringaresinol 
• 77-78-1 dimethyl sulfate 
• 886989-85-1 (1S,4S,5S,8S)-4,8-bis(3,4,5-trimethoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane-2,6-dione 
• 487-35-4 (+/-)-syringaresinol 
• 2373-80-0 3,4-methylenedioxy-trans-cinnamic acid 
• 20329-98-0 (E)-3,4,5-trimethoxy-cinnamic acid 
• 886989-84-0 (S)-1-[(E)-3-(3,4,5-trimethoxyphenyl)propenoyl]pyrrolidine-2-carboxylic acid 
• 886989-89-5 (1S,2R,3R,4S)-2,3-bis(hydroxymethyl)-1,4-bis(3,4,5-trimethoxyphenyl)butane-1,4-diol 

Downstream Products

• 60619-98-9 (+)-syringaresinol dimethyl ether 
• 24192-64-1 2,6-bis(3,4,5-trimethoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane 

Relevant articles and documents

Electochemical asymmetric dimerization of cinnamic acid derivatives and application to the enantioselective syntheses of furofuran lignans

A new electrochemical method for the asymmetric oxidative dimerization of cinnamic acid derivatives has been developed. This method enabled the enantioselective syntheses of furofuran lignans, yangambin, sesamin and eudesmin.

Simple and efficient asymmetric synthesis of furofuran lignans yangambin and caruilignan A

A novel asymmetric dimerization of cinnamic acid derivative was achieved in high efficiency and high stereoselectivity. By using the reaction as a key step, two furofuran lignans, yangambin and caruilignan A were synthesized in optically pure form in only 5 and 6 steps, respectively. Georg Thieme Verlag Stuttgart.